阿瑟·克莱曼 (Arthur Kleinman，又名 凯博文)，曾先后担任哈佛医学院社会医学部主任和哈佛大学人类学系主任，现任哈佛研究生院及医学院终身教授。

莱娜德拉·达斯(Renendra Das)，普林斯顿大学副研究员，曾任印度德里经济学院教授。

安妮·洛弗尔(Anne Lovell)，法国国家卫生研究员高级研究员，《心理健康与社会》主编。

苏珊·怀特(Susan Wright)，丹麦哥本哈根大学人类学研究所教授。

戴维·希利(David Healy)，英国卡迪夫大学精神病学教授。

贝蒂·柯亚唐多(Betty Kyaddondo)，内科医生，现任乌干达艾滋病信息中心医疗官员。

In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. Together they demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from pre-clinical research to human testing, marketing, distribution, prescription, and consumption. Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/Aids prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals. Some essays show how individual and communal identities are affected by the marketing and availability of medications. Among these are an exploration of how the pharmaceutical industry shapes popular and expert understandings of mental illness in North America and Great Britain. There is also an examination of the agonizing choices facing Ugandan families trying to finance aids treatment. Several essays explore the inner workings of the emerging international pharmaceutical regime. One looks at the expanding quest for clinical research subjects; another at the entwining of science and business interests in the Argentine market for psychotropic medications. By bringing the moral calculations involved in the production and distribution of pharmaceuticals into stark relief, this collection charts urgent new territory for social scientific research.